Ecolab Life Sciences announced the opening of a new Bioprocessing Applications Lab in Dongtan, Korea, its first bioprocessing facility in Asia. The new center further strengthens the company’s global Life Sciences footprint and supports customers operating in one of the world’s most advanced biopharmaceutical manufacturing markets.

Ecolab Life Sciences has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manufacturing process. Purolite™ AP+50 is an affinity chromatography resin with a 50-micron bead size offering the highest dynamic binding capacity of the AP resin platform while providing excellent durability for monoclonal antibody capture. It also leverages Ecolab’s patented Jetted resin bead manufacturing technology, an innovative approach that enables lot-to-lot consistency and shorter lead times.

This facility supports biopharma customers with applications and process development for biotherapeutic molecule purification, offering technical support from small-scale to full commercial production. Equipped with high-throughput process development tools and manufacturing scale chromatography columns, the lab helps biotech firms optimize processes and reduce costs. This new lab complements Ecolab’s existing European Applications and Research & Development Lab in Wales, UK.

Skytree, a pioneering climate tech company specializing in carbon utilization and removal solutions, today announced it has signed strategic multi-year development and supply agreements with Purolite, an Ecolab company and leading manufacturer of synthetic and agarose-based purification resins, to jointly develop energy-efficient and cost-effective CO2 capture material for use in Direct Air Capture (DAC) utilization and storage initiatives. This next generation of capture material has the potential to increase capture capacity, drive down energy consumption, and lower the cost per ton of captured CO2 from the atmosphere. As part of this relationship, Purolite will be the sole resin material supplier for Skytree DAC technology.

Ecolab today announced that its Purolite resin business, together with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes. This new affinity resin is being introduced at the BIO International Convention (BIO 2024), being held June 3-6 in San Diego. This latest innovation marks a significant milestone in Purolite’s long-term strategic partnership with Repligen, further solidifying Ecolab’s dedication to driving advancements in the bioprocessing industry.

Purolite, an Ecolab company, announced the launch of Praesto® CH1 chromatography resin, a new 70μm (micron) agarose-based resin designed to purify specialized mAbs such as bispecific and Fc mutants to recombinant antibody fragments. This latest innovation was developed as part of a multi-year strategic partnership with Repligen Inc. and leverages Purolite’s patented Jetting manufacturing process and Repligen’s leading ligand technology.

Purolite, a leading provider of premium ion exchange resin technology, continues its global expansion to meet a growing market and increasing customer demand. To better serve customers in China and the Asia Pacific region, Purolite has also announced plans to build a new resin plant for water and industrial markets in the Quzhou Industrial Park. Construction will begin in 2024, with deliveries to customers expected to commence in late 2026.

Ecolab Inc., the world’s water, hygiene, and infection prevention company, today announced a further expansion of its Purolite business with the addition of a new biologics resin manufacturing facility in Landenberg, Pennsylvania.

The award recognizes Purolite's commitment to the King of Prussia area and the completion of the company's new manufacturing facility.

Purolite, an Ecolab company, celebrated the opening of its new pharmaceutical manufacturing facility in King of Prussia, Pa. The new plant, will produce ion exchange resins for vital healthcare development and pharmaceutical APIs to meet the growing demand for existing and future applications and therapies.

Leading resin manufacturer Purolite extends and signs strategic partnership with Repligen for five new high-performance ligands to meet evolving bioprocessing market needs

Thursday, October 13 to celebrated the achievement of Purolite, an Ecolab company’s increased bioprocessing resin production to meet the growing demand for biopharmaceutical products globally.

Since 2015, Purolite and Alvotech have developed a strong partnership, fostered by a shared goal of improving the accessibility of essential biologic medicines. To achieve this, both companies focus on ingenuity and agility to enable more cost-effective solutions.

Purolite, a leading manufacturer of synthetic and agarose-based resins used in the bioprocessing industry, has been awarded the prestigious Queen’s Award for Enterprise in the International Trade category.

Purolite UK has kicked off the year by announcing Maggie’s Cancer Care Centre in Cardiff as its inaugural UK Charity of the Year for 2022.

Purolite Ltd., a leading manufacturer of resin-based separation, purification and extraction technologies, today announces that its Praesto agarose-based Protein A and Ion Exchange chromatography resins will be made available in South Korea and Singapore.

WuXi Biologics, a global company with leading open-access biologics technology, will utilize Praesto® Jetted A50 to provide their customers with additional choices for affinity chromatography resins for a range of downstream processes for monoclonal antibody purification.

Purolite's Praesto range of agarose-based chromatography resins move into the commercial manufacturing of FDA-approved biotherapeutics.

Purolite is pleased to announce our partnership with PharmNXT Biotech, for the supply and distribution of the Praesto® range of chromatography resins in India.